Bullish indicating open at $55-$60, IPO prices at $37
Investing.com - JPMorgan upgraded Nutrien (NYSE:NTR) from Neutral to Overweight on Monday, raising its price target to $68.00 from $56.00. The $27 billion market cap company currently trades at a P/E ratio of 20.1x and offers a dividend yield of 3.91%. According to InvestingPro data, seven analysts have recently revised their earnings estimates upward for the upcoming period.
The upgrade reflects JPMorgan’s preference for fertilizer companies over petrochemical companies in the current market environment. The firm cited favorable conditions in fertilizer markets, including low inventories, tight supply/demand balances, and promising multi-year prospects with moderate capacity increases. InvestingPro analysis reveals that Nutrien’s financial health score is rated as FAIR, with particularly strong marks in profitability metrics.
JPMorgan noted that fertilizer companies are "not especially expensive," with average EV/EBITDA multiples, high free cash flow yields, and strong balance sheets. This contrasts with petrochemical companies, which the firm described as "not especially inexpensive" with above-average multiples, low free cash flow yields, and rising debt levels.
The firm pointed out that petrochemical companies face challenging conditions including oversupply, shrinking spreads due to weakening oil prices, large capacity additions, ample inventories, and weak demand.
Nutrien, a major player in the agricultural inputs sector, produces and distributes potash, nitrogen, and phosphate products for agricultural, industrial, and feed customers worldwide.
In other recent news, Nutrien Ltd. reported its second-quarter 2025 earnings, revealing an earnings per share (EPS) of $2.65. This result surpassed consensus estimates of $2.39, indicating a positive surprise of 10.88%. However, the company’s revenue did not meet expectations, coming in at $10.44 billion compared to the forecasted $10.55 billion. Despite the EPS beat, the revenue shortfall was noted by investors. Additionally, Jefferies adjusted its outlook on Nutrien, lowering the stock price target from $66.00 to $61.00 while maintaining a Hold rating. This adjustment reflects a mixed outlook on the company’s performance. These developments are part of Nutrien’s recent financial activities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.